A differential expression and responsiveness of TLR4 on CD14+ cells in DHF patients could be one relevant factor that leads to different clinical outcomes, but new studies are necessary to understand the precise role of these pathways on DHF development in humans. This evidence concerns the gene CD14 and Dengue hemorrhagic fever.